Clinical Trials Directory

Trials / Completed

CompletedNCT03338933

Neurobiology of Alcohol and Nicotine Co-Addiction

Status
Completed
Phase
Study type
Observational
Enrollment
109 (actual)
Sponsor
VA Office of Research and Development · Federal
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This proposal addresses the critical absence of information about the neurobiology of recovery from Alcohol Use Disorder (AUD) in alcohol and nicotine users.

Detailed description

This proposal addresses the critical absence of information about the neurobiology of recovery from Alcohol Use Disorder (AUD) in alcohol and nicotine users. AUD and nicotine use disorder (NUD) are the most commonly abused (non-prescription) substances in the U.S. Co-addiction is particularly high in military veterans. Although nationwide estimates peg the rate of AUD/NUD co-addiction at 80%, the Substance Abuse Treatment Program (SATP) at the Veterans Affairs Portland Health Care System (VAPORHCS) finds that 90% of veterans treated for AUD also meet criteria for NUD. The investigators hypothesize that a support vector machine learning algorithm will be able to use the measures to classify subjects as AUD, NUD both or neither and that the algorithm will predict outcome (sobriety or relapse) at three months.

Conditions

Interventions

TypeNameDescription
BEHAVIORALmagnetic resonance imaging (MRI)All subjects will undergo a baseline MRI and subjects in both alcohol groups (alcohol use disorder and combined alcohol and nicotine use disorder) will undergo a followup MRI 3 months after baseline.

Timeline

Start date
2018-02-08
Primary completion
2023-01-03
Completion
2023-01-03
First posted
2017-11-09
Last updated
2025-02-13
Results posted
2025-02-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03338933. Inclusion in this directory is not an endorsement.